Advances in Prognostic Methylation Biomarkers for Prostate Cancer

There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Dilys Lam, Susan Clark, Clare Stirzaker, Ruth Pidsley
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI AG 2020-10-01
Серии:Cancers
Предметы:
DNA methylation
epigenetics
biomarkers
circulating DNA
cfDNA
prostate cancer
Online-ссылка:https://www.mdpi.com/2072-6694/12/10/2993
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы